Patents by Inventor Michael Arend

Michael Arend has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel nitrogen-containing heteroaryl compounds and methods of use thereof
    Publication number: 20060217416
    Abstract: The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
    Type: Application
    Filed: May 26, 2006
    Publication date: September 28, 2006
    Inventors: Michael Arend, Lee Flippin, Volkmar Guenzler-Pukall, Wen-Bin Ho, Eric Turtle, Xiaohui Du
  • Novel thienopyridine compounds, and methods of use thereof
    Publication number: 20060199836
    Abstract: The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF).
    Type: Application
    Filed: March 2, 2006
    Publication date: September 7, 2006
    Inventors: Eric Turtle, Lee Flippin, Michael Arend, Heng Cheng
  • Methods of increasing endogenous erythropoietin (EPO)
    Publication number: 20060183695
    Abstract: The present invention relates to methods for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo. Methods for treating, pretreating or preconditioning, or preventing erythropoietin-associated conditions are also included. Compounds for use in these methods are provided, as are methods of identifying such compounds.
    Type: Application
    Filed: April 17, 2006
    Publication date: August 17, 2006
    Applicant: FibroGen, Inc.
    Inventors: Stephen Klaus, Al Lin, Thomas Neff, Qingjian Wang, Volkmar Guenzler-Pukall, Michael Arend, Lee Flippin, Alex Melekhov
  • Methods of increasing endogenous erythropoietin (EPO)
    Publication number: 20060178317
    Abstract: The present invention relates to methods for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo. Methods for treating, pretreating or preconditioning, or preventing erythropoietin-associated conditions are also included. Compounds for use in these methods are provided, as are methods of identifying such compounds.
    Type: Application
    Filed: April 17, 2006
    Publication date: August 10, 2006
    Applicant: FibroGen, Inc.
    Inventors: Stephen Klaus, Al Lin, Thomas Neff, Qingjian Wang, Volkmar Guenzler-Pukall, Michael Arend, Lee Flippin, Alex Melekhov
  • Methods of increasing endogenous erythropoietin (EPO)
    Publication number: 20060178316
    Abstract: The present invention relates to methods for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo. Methods for treating, pretreating or preconditioning, or preventing erythropoietin-associated conditions are also included. Compounds for use in these methods are provided, as are methods of identifying such compounds.
    Type: Application
    Filed: April 17, 2006
    Publication date: August 10, 2006
    Applicant: FibroGen, Inc.
    Inventors: Stephen Klaus, Al Lin, Thomas Neff, Qingjian Wang, Volkmar Guenzler-Pukall, Michael Arend, Lee Flippin, Alex Melekhov